Global Molecular Imaging Market Report to 2029 - Players Include Hologic, Hitachi, Siemens and Samsung Medison Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Molecular Imaging Market, by Application (Cancer, Heart Disease, Brain Disorder), by Technology (Gamma Camera, SPECT, PET, Magnetic Resonance Spectroscopy), by End User (Hospital, Diagnostic Imaging Centres), and by Region - and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The global molecular imaging market is estimated to be USD 6,750.1 million in 2021 and is expected to witness a CAGR of 7.84% during the forecast period.

Companies Mentioned

• Fujifilm Holdings Corp. (Japan)
• Carestream Health (U.S)
• GE Healthcare (U.S)
• Hologic Inc. (U.S)
• Hitachi Ltd. (Japan)
• Siemens AG (Germany)
• Samsung Medison (South Korea)
• Shimadzu Corp. (Japan)
• Philips Healthcare (Netherlands)
• Toshiba Medical Systems Corp. (Japan)

Elderly population in emerging countries such as China and India, the adoption and advancement in technologies such as PET/CT, non-ionizing imaging techniques, and growing demand for efficient and accurate imaging systems for better and effective diagnoses of diseases are driving the global market. However, continuous improvement and innovation in molecular imaging technologies and high cost of the technologies are expected to hinder the global molecular imaging market growth.

By Technology

On the basis of technology, the global market is segmented into gamma cameras, single-photon emission computed tomography (SPECT), positron emission tomography (PET), magnetic resonance spectroscopy, optical imaging, and molecular ultrasound imaging. A positron emission tomography (PET) is a non-invasive and simple technology. It delivers improved imaging data and increases patient convenience by decreasing the scanning session count, thus PET technology dominates the global market. PET as an imaging method depends on its ability to discover chronic diseases at early stages.

By Application

On the basis of application, the global market is segmented into cancer, heart disease, brain disorder, gastrointestinal disorder, lung disorder, bone disorder, and others. Cancer segment accounted for the largest revenue share in the global market in 2021. Increasing occurrence of various chronic diseases such as cancer and other genetic disorders are propelling demand for early disease diagnosis eventually driving the medical imaging market growth.

By End User

On the basis of end-user, the market is categorized into hospitals, diagnostic imaging centers, and others. Hospitals & clinics accounted for the largest market share the market in 2021. The factors including well-resourced operating & surgical rooms, attendance of skilled healthcare professionals, and improved health coverage for healthcare services from various private and group insurance, among others, are accountable for the market dominance of hospitals.

Regional Insights

North America dominated the global market in 2021 and is projected to maintain its domination during the forecast period. The reason for this market share is the increase owing to increasing healthcare aid from government and private organizations to develop technologically advanced medical systems that will help in fulfilling the demand of increasing population suffering from various diseases.

Asia Pacific market is projected to grow at a fastest CAGR during the forecast period. Trends such as growing senior population, urbanization, prevalence of chronic diseases, and demand for improved diagnostic care in the region expected to boost the regional growth.

Key Topics Covered:

1. Research Methodology

2. Introduction: Molecular Imaging

3. Executive Summary

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraint

4.3. Market Opportunities

4.4. Market Trends

4.5. Market Challenges

5. Market Environment Analysis

5.1. Porter's 5 Forces Analysis

5.2. PESTEL Analysis

5.3. Value Chain Analysis

5.4. SWOT Analysis

5.5. Benchmark

6. COVID-19 Impact Analysis: Molecular Imaging Market

6.1. COVID-19: Overview

6.2. COVID-19 Impact on the Global Market

6.3. COVID-19 Impact on the Regional Markets

7. Market Analysis by Application

8. Market Analysis by Technology

9. Market Analysis by End User

10. Regional Market Analysis

11. North America Molecular Imaging Market

12. Europe Molecular Imaging Market

13. Asia Pacific Molecular Imaging Market

14. Latin America Molecular Imaging Market

15. MEA Molecular Imaging Market

16. Competitor Analysis

16.1. Market Share Analysis, 2021 & 2029

16.2. Competitive Mapping

16.3. Key Players Market Place Analysis

16.4. Major Recent Developments

17. Company Profiles

18. Conclusion & Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/hfluyd